Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/11/1998EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
03/11/1998EP0827510A1 Synthetic peptide analogs of cross-linked n-telopeptides of type i collagen
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998EP0827508A2 Soluble, cleavable substrates of the hepatitis c virus protease
03/11/1998EP0827502A1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
03/11/1998EP0827412A1 Peptide radiopharmaceutical applications
03/11/1998EP0827407A1 POST-TRANSLATIONAL ACTIVATION OF TGF-$g(b) 1? INVOLVING THE TSP-1 RECEPTOR CD36
03/11/1998EP0696919A4 Diagnosis and treatment of erectile dysfunction
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998EP0656785B1 Method for inhibiting hiv replication using il-4
03/11/1998EP0556178B1 Use of protease nexin-i to mediate wound healing
03/11/1998EP0503002B1 Antisense oligonucleotide inhibition of papillomavirus
03/11/1998CN1175977A Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw* 1601 and uses thereof
03/11/1998CN1175956A Novel protein and method for production of same
03/11/1998CN1175955A Helicobacter pylori antigen
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175902A Method and compositions for lipidization of hydrophilic molecules
03/11/1998CN1175638A Process for construction and purifying of recombinant human lymph toxin alpha deriv. a
03/11/1998CN1175586A Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof
03/11/1998CN1175585A Double antigen contg hepatitis B virus and hepatitis C virus core antigen simultaneously
03/11/1998CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726293 Affinity purification methods involving imidazole elution
03/10/1998US5726291 Amylase inhibitors
03/10/1998US5726290 Soluble analogues of integrins
03/10/1998US5726288 Dna with nucleic acid sequence
03/10/1998US5726286 Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains
03/10/1998US5726243 Mild solid-phase synthesis of aligned, branched triple-helical peptides
03/10/1998US5726200 Treatment of obesity, gastrointestinal disorders, tumors, drug withdrawal; useful as antipsychotic, antianxiety, antiulcer agents;
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726158 Peptide derivatives
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726155 Lmwg=low molecular weight gtp-binding proteins; inhibiting superoxide production in phagocytic cells; treating inflammation, autoimune disorders, gout, adult respiratory distress syndrome, asthma, myocardial infarction,
03/10/1998US5726153 Synthetic peptides for arterial imaging
03/10/1998US5726152 Dimeric mitogens, vascular development and repair
03/10/1998US5726151 Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726147 Human mutant tissue factor compositions useful as tissue factor antagonists
03/10/1998US5726058 Purified dna molecule having specified nucleotide sequence
03/10/1998US5726057 Nucleotide sequences for genes
03/10/1998US5726044 Expression and export technology of proteins as immunofusins
03/10/1998US5726043 Process for the production of protease inhibitors
03/10/1998US5726042 Expression of heterologous proteins in Bacillus megaterium utilizing sporulation promoters of Bacillus subtilis
03/10/1998US5726040 Cosmetic compositions including tropoelastin isomorphs
03/10/1998US5726038 DNA construct encoding the YAP3 signal peptide
03/10/1998US5726037 Host cells and method of producing soluble analogues of integrins
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726035 Recombinant production of mammalian calcium channel gamma subunits
03/10/1998US5726034 Plant extracts separated from protein, contacting with enzyme for cleavage of glucosides
03/10/1998US5726027 Method for treatment of insulin resistance
03/10/1998US5726024 p53as protein and antibody therefor
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5726021 Pretreating cells by enzyme degradation, magnesium chelators, nonionic and anionic detergents and heating
03/10/1998US5726019 Target mutant nucleotide sequence for antitumor agents
03/10/1998US5726018 Nucleic acid based assays to detect a novel mammalian protein associated with uncontrolled cell division
03/10/1998US5726017 High affinity HIV-1 gag nucleic acid ligands
03/10/1998US5726016 Compositions and methods for diagnosis of diseases associated with actinobacillus actinomycetemcomitans infection
03/10/1998US5726014 Screening assay for the detection of DNA-binding molecules
03/10/1998US5725864 Contacting susceptible lymphoid cells with antiviral amount of iron-binding protein or derivative thereof
03/10/1998US5725863 Vaccine
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/10/1998US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
03/10/1998US5725851 Method and compositions for treating injury
03/10/1998US5725850 Use of CSF-1 to treat tumor burden
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/10/1998CA1339707C Formulations for recombinant beta-interferon
03/06/1998CA2209890A1 Apoptotic agents for tumor cells of the nervous system
03/05/1998WO1998009171A1 Novel chemokine receptor inhibition assay
03/05/1998WO1998008979A1 Method and compounds for controlling capacitative calcium ion entry into mammalian cells
03/05/1998WO1998008969A1 Soluble interleukin-1 receptor accessory molecule
03/05/1998WO1998008965A2 Cd95 regulatory gene sequences and transcription factors
03/05/1998WO1998008962A1 Early seed 5' regulatory sequence
03/05/1998WO1998008961A2 Endosperm and nucellus specific genes, promoters and uses thereof
03/05/1998WO1998008959A1 In vivo protein synthesis method
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008954A2 Production of heme and recombinant hemoproteins
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008952A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998WO1998008951A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998WO1998008950A1 Novel monocyte activating cytokine
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008948A1 Protein targeting to glycogen
03/05/1998WO1998008947A1 Enhancement of dna immunization through the use of cytokines
03/05/1998WO1998008946A1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis
03/05/1998WO1998008945A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998WO1998008943A1 Hla-drb1 peptides with specific binding affinity for hla-dq molecules: prevention and treatment of rheumatoid arthritis
03/05/1998WO1998008936A1 Recombinant canine herpesvirus
03/05/1998WO1998008934A1 Serum-free mammalian cell culture medium, and uses thereof
03/05/1998WO1998008932A1 Insecticidal protein toxins from $i(photorhabdus)
03/05/1998WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
03/05/1998WO1998008873A1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery
03/05/1998WO1998008872A1 Glp-2 derivatives
03/05/1998WO1998008871A1 Glp-1 derivatives
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008869A1 Hematopoietic stem cell growth factor (scgf)
03/05/1998WO1998008868A1 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
03/05/1998WO1998008866A1 Bau, a bin1 interacting protein, and uses therefor
1 ... 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 ... 2916